Author Topic: Issue 119 Sept. 2011 AN assoc. Notes  (Read 11501 times)

Mickey

  • Hero Member
  • *****
  • Posts: 753
Issue 119 Sept. 2011 AN assoc. Notes
« on: September 16, 2011, 04:34:57 pm »
Very interesting Danish study having to do with W+W. Alot of info to mull over but what interested me most was the last sentence that NO AN grew after 5 years, with a mean follow-up of about four years  in that data... Best wishes, Mickey

leapyrtwins

  • Hero Member
  • *****
  • Posts: 10826
  • I am a success story!
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #1 on: September 16, 2011, 09:10:35 pm »
Sounds interesting.  I got my electronic copy of Notes a few days ago, but haven't had time to read it.

Will definitely have to check out that article. 

Jan
Retrosig 5/31/07 Drs. Battista & Kazan (Hinsdale, Illinois)
Left AN 3.0 cm (1.5 cm @ diagnosis 6 wks prior) SSD. BAHA implant 3/4/08 (Dr. Battista) Divino 6/4/08  BP100 4/2010 BAHA 5 8/2015

I don't actually "make" trouble..just kind of attract it, fine tune it, and apply it in new and exciting ways

Barb909

  • New Member
  • *
  • Posts: 47
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #2 on: September 16, 2011, 09:12:33 pm »
I, too, found it very interesting. I was at the symposium and when I heard this my ears certainly tuned in, thinking I had heard incorrectly. My AN began deep inside my inner ear, was small when diagnosed, has grown 1mm in 1.5 years, and I am older than most, almost 59. My doctor, Cincinnati Dr. Theodosopolous, said that every year I go with no growth, the higher the chances that it will not grow.

I plan to test this study, and his theory, and prove them both credible!

Barb
Feb. 2010    4 x 8 x 5mm
June 2011   4.7 x 8.9 x 4.0mm
May 2012    4.5 x 9.1 x 3.9mm
Sept. 2013   5 x 10.1 x 5mm
Feb. 2015     6 x 13 x 5 mm
In IAC near cochlea
Mild hearing loss, tinnitus
W & W, thinking about treatment

CHD63

  • Hero Member
  • *****
  • Posts: 3235
  • Life is good again!!
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #3 on: September 17, 2011, 08:38:20 am »
Barb .....

I hope so too!!!

Clarice
Right MVD for trigeminal neuralgia, 1994, Pittsburgh, PA
Left retrosigmoid 2.6 cm AN removal, February, 2008, Duke U
Tumor regrew to 1.3 cm in February, 2011
Translab AN removal, May, 2011 at HEI, Friedman & Schwartz
Oticon Ponto Pro abutment implant at same time; processor added August, 2011

Mickey

  • Hero Member
  • *****
  • Posts: 753
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #4 on: September 17, 2011, 10:04:21 am »
Hi Barb! I was diognosed at 58 and am now almost 63. Everything has been "stable" W+W. I think its a great study which makes W+W a good option for more people who fit the bill...   Join the W+W brigade! Best wishes Mickey

rm516

  • Jr. Member
  • **
  • Posts: 65
  • 'incremental improvements' everyday!
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #5 on: September 17, 2011, 01:47:51 pm »
Please provide the link to study or website, as I could not find it....
Meanwhile, I got a recent MRI: It is "Stable" per Radiologist (3 yrs), although dimensions were 2.9 cm vs 2.7 cm but doctor noted on the report that  slight variation could be from slice selection but "stable" ?
Nevertheless, no deterioration in hearing, still wonky head if too tired or stressed , no other changes. W&W continues..
Diagnosed AN in 2008,  3.2 cm CPA round, retrosigmoid surgery performed by Dr. M. Sisti, Columbia Pres.Hospital  NY, in Jan 2013, After surgery no major issues, Hearing retained (>50% ). However, 2 YRs post surgery MRI shows a further decrease in the size of residual AN! No GK or any therapy needed.

Keeping Up

  • Sr. Member
  • ****
  • Posts: 253
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #6 on: September 17, 2011, 10:11:34 pm »
I can't find the study either - but is supportive of the information I have received from my ENT (and his study - eagerly awaiting his 15 year review of patients).

Most ANs (65%, and I think with a focus on the smaller and intracanicular tumours) didn't show any growth over a ten year period.  The majority of tumours which 'failed' conservative management fail within 3 years of diagnosis.  Most people will have read my rhyming off of this doctor's study previously.  I think the 10 year was released in 2007/2008 so am hoping for the 15 year in 2012!

I like the 5 year stat (I am assuming based on the text here - that if a tumour shows no (or minimal????) growth in the first five years of growth, that none showed growth in the next four years [but am not certain!]

Hoping to get off easy with this tumour.  (Hearing is something completely different ... that I am losing for sure!)

It is nice to see reinforcement to the W&W, it is sometimes difficult to sit back and just wait - but remain confident it is my best option for now!

Ann
dx Dec/08 - 5mm x 8mm AN
'watch and wait'

Mickey

  • Hero Member
  • *****
  • Posts: 753
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #7 on: September 18, 2011, 05:58:35 pm »
Just to clarify things a little, this is a booklet which is mailed out by ANA monthly or quarterly...I believe you have to be a member to get one. Very informative...Mickey

Ellen K

  • New Member
  • *
  • Posts: 34
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #8 on: September 19, 2011, 10:38:35 am »
I think the article said that the one downside of the study was that "growth" was only defined as growth outside the IAC, but that overall the study was an excellent case for W&W.
3mm diagnosed December 2010 when I was 45. Very unusual presentation - severe vertigo, then dizziness daily, now just occasional dizziness, but it can be debilitating some days. No hearing loss! But yes to ear fullness and wonky brain. Watch and wait.

sharonov

  • Full Member
  • ***
  • Posts: 183
  • 1.7 X 1.3 X 1.1. Retro sigmoid at House, Schwartz
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #9 on: September 19, 2011, 03:44:39 pm »
Like the rest of you, I was more than thrilled to read Dr. Link's report on the Danish study.  I've been W & W for I think 5 years now (I'm losing track of time) and am currently 69.  My tumour was 1.4 x 1.3 x 1.1 with no symptoms other than hearing loss.  Last MRI showed the middle number to be 1.6 and my doctor immediately wanted to schedule me for Gamma Knife (his specialty; they all want to do their own specialty.)  I gently reminded him that he had told me, 5 years ago, not to do anything because I'd lose 15% of my hearing if I had radiosurgery.  He quickly backtracked and said that recent studies showed that the hearing loss would continue anyway.  And, indeed, mine has.  I have very poor speech recognition in my affected year.  It's so bad that the audiologist suggested not getting a hearing aid as I would then just have louder garble.

Well, nonetheless, I don't want to risk any of the other side effects unless I absolutely have to, so was overjoyed to read the study.  Hopefully all of you who haven't been able to access the info yet have managed to do so.
Sharon

G_Man

  • Full Member
  • ***
  • Posts: 123
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #10 on: September 25, 2011, 10:04:57 pm »
Mickey  I was there when he said it.  I was there when so many doctors said so much I was dizzy.  Which in that case was a good thing.  Anyway, seeing it in print made me feel better, like I wasn't just imagining or dreaming it.  At the dinner after the NYC meeting on saturday I overheard someone who said something I've heard too many times.  He said, "I don't know why anyone would choose Watch and Wait."  I heard at least 2 doctors say this at the symposium.  Well we know why.  Now studies are starting to prove this course more and more appropriate for some of us.  I hope you and I are refered to in future studies when we are W+W for 20+ years (fingers crossed). 
Glen
Diag: 08/11/2009 Left side
AN: 0.6cm.  65% Hearing loss, tinnitus, fullness, minor motion issues.
hearing loss over 25+ years.  MRI in 2000 showed nothing.
Optical Atrophy from infantcy
Watch and Wait.
As of 2017 I am on a 2 year MRI frequency.

Mickey

  • Hero Member
  • *****
  • Posts: 753
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #11 on: September 25, 2011, 10:32:07 pm »
Hi Glen! Nice seeing you at the meeting. Alot of interesting things about W+W.  I like NYU`s approach to all methods .  Impressing me especially  with there treatment orally which is showing alot of promise in future for W+W.  Presentation on Gamma Knife was also outstanding... Keep the faith!

Best wishes, Mickey
« Last Edit: September 26, 2011, 02:08:48 pm by Jim Scott »

rm516

  • Jr. Member
  • **
  • Posts: 65
  • 'incremental improvements' everyday!
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #12 on: September 26, 2011, 06:49:49 pm »
<<<<i LIKE NYU`s approach to all methods .  Impressing me especially  with there treatment orally which is showing alot of promise in future for W+W.>>>
can you please elaborate,,,
Diagnosed AN in 2008,  3.2 cm CPA round, retrosigmoid surgery performed by Dr. M. Sisti, Columbia Pres.Hospital  NY, in Jan 2013, After surgery no major issues, Hearing retained (>50% ). However, 2 YRs post surgery MRI shows a further decrease in the size of residual AN! No GK or any therapy needed.

Mickey

  • Hero Member
  • *****
  • Posts: 753
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #13 on: September 26, 2011, 07:15:42 pm »
NYU is giving a certain medicine by mouth to certain volunteers with the hope of tumor shrinkage, primarily NF2. I forgot the name of the drug which was mentioned at the NYANA meeting on Saturday. Best wishes, Mickey

rm516

  • Jr. Member
  • **
  • Posts: 65
  • 'incremental improvements' everyday!
Re: Issue 119 Sept. 2011 AN assoc. Notes
« Reply #14 on: September 26, 2011, 07:45:13 pm »
Is it Avastin or Lapatinib ?
These are clinical trial/study medicine but only used for NF2.
What about just AN ?
Thanks for reply..
Diagnosed AN in 2008,  3.2 cm CPA round, retrosigmoid surgery performed by Dr. M. Sisti, Columbia Pres.Hospital  NY, in Jan 2013, After surgery no major issues, Hearing retained (>50% ). However, 2 YRs post surgery MRI shows a further decrease in the size of residual AN! No GK or any therapy needed.